Evidence map›Paper›PMID 29261103›Full record

ArticleMolecules (Basel, Switzerland)2017

Calli Essential Oils Synergize with Lawsone against Multidrug Resistant Pathogens.

Sameh S M Soliman, Abrar I Alsaadi, Eman G Youssef, Gregory Khitrov, Ayman M Noreddin, Mohamed I Husseiny, Ashraf S Ibrahim

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. The Anti-Plants (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Design and synthesis of new drugs inhibitors of Candida albicans hyphae and biofilm formation by upregulating the expression of TUP1 transcription repressor gene.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2020
    Article
  13. Essential Oil-Based Design and Development of Novel Anti-Molecules (Basel, Switzerland) · 2020
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Sameh S M SolimanSharjah Institute for Medical Research, and College of Pharmacy, University of Sharjah, P.O. Box 27272, Sharjah, UAE. ssoliman@sharjah.ac.ae.
Abrar I AlsaadiDivision of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA 90509, USA. aalsaadi1@toromail.csudh.edu.
Eman G YoussefDivision of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA 90509, USA. emangouda@psas.bsu.edu.eg.
Gregory KhitrovMolecular Instrumentation Center, Department of Chemistry, University of California Los Angeles, Los Angeles, CA 90095, USA. khitrov@chem.ucla.edu.
Ayman M NoreddinSharjah Institute for Medical Research, and College of Pharmacy, University of Sharjah, P.O. Box 27272, Sharjah, UAE. anoreddin@sharjah.ac.ae.
Mohamed I HusseinyFaculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt. melsayed@coh.org.ORCID 0000-0002-3470-2858
Ashraf S IbrahimDivision of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, CA 90509, USA. ibrahim@labiomed.org.
University of California, Los Angeles · USZagazig University · EGBeni-Suef University · EGEastern Virginia Medical School · USThe Lundquist Institute · US

Funding

Novel Toxins and Receptors in Mucormycosis Pathogenesis and TreatmentR01AI063503 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI IBRAHIM, ASHRAF S. · 2006 to 2025
$7.3M
NIAID NIH HHS R01 AI063503
6 · The paper itself

Abstract

The fast development of multi-drug resistant (MDR) organisms increasingly threatens global health and well-being. Plant natural products have been known for centuries as alternative medicines that can possess pharmacological characteristics, including antimicrobial activities. The antimicrobial activities of essential oil (Calli oil) extracted from the

Indexed as

Anti-Bacterial AgentsAntifungal AgentsCandidaCell SurvivalDrug Resistance, Multiple, BacterialDrug Resistance, Multiple, FungalDrug SynergismEndothelial CellsErythrocytesHumansLiposomesMicrobial Sensitivity TestsNaphthoquinonesOils, VolatilePlant OilsRhizopusAnti-Bacterial AgentsAntifungal AgentslawsoneLiposomesNaphthoquinonesOils, VolatilePlant OilsantimicrobialsCalligonumcombination treatmentessential oillawsoneliposomes

Identifiers

PMID29261103
PMCPMC6034512
OpenAlexW2776992533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.